Silverfin false false 30/04/2024 01/05/2023 30/04/2024 Mr M A R Luscombe 29/04/2019 04 October 2024 The principal activity of the company during the year was that of emergency response training and private ambulance services. 11967547 2024-04-30 11967547 bus:Director1 2024-04-30 11967547 2023-04-30 11967547 core:CurrentFinancialInstruments 2024-04-30 11967547 core:CurrentFinancialInstruments 2023-04-30 11967547 core:Non-currentFinancialInstruments 2024-04-30 11967547 core:Non-currentFinancialInstruments 2023-04-30 11967547 core:ShareCapital 2024-04-30 11967547 core:ShareCapital 2023-04-30 11967547 core:RetainedEarningsAccumulatedLosses 2024-04-30 11967547 core:RetainedEarningsAccumulatedLosses 2023-04-30 11967547 core:Goodwill 2023-04-30 11967547 core:Goodwill 2024-04-30 11967547 core:PlantMachinery 2023-04-30 11967547 core:Vehicles 2023-04-30 11967547 core:OfficeEquipment 2023-04-30 11967547 core:ComputerEquipment 2023-04-30 11967547 core:PlantMachinery 2024-04-30 11967547 core:Vehicles 2024-04-30 11967547 core:OfficeEquipment 2024-04-30 11967547 core:ComputerEquipment 2024-04-30 11967547 core:CurrentFinancialInstruments core:Secured 2024-04-30 11967547 bus:OrdinaryShareClass1 2024-04-30 11967547 bus:OrdinaryShareClass2 2024-04-30 11967547 2023-05-01 2024-04-30 11967547 bus:FilletedAccounts 2023-05-01 2024-04-30 11967547 bus:SmallEntities 2023-05-01 2024-04-30 11967547 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 11967547 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 11967547 bus:Director1 2023-05-01 2024-04-30 11967547 core:Goodwill core:TopRangeValue 2023-05-01 2024-04-30 11967547 core:Goodwill 2023-05-01 2024-04-30 11967547 core:PlantMachinery 2023-05-01 2024-04-30 11967547 core:Vehicles 2023-05-01 2024-04-30 11967547 core:OfficeEquipment core:TopRangeValue 2023-05-01 2024-04-30 11967547 core:ComputerEquipment core:TopRangeValue 2023-05-01 2024-04-30 11967547 2022-05-01 2023-04-30 11967547 core:OfficeEquipment 2023-05-01 2024-04-30 11967547 core:ComputerEquipment 2023-05-01 2024-04-30 11967547 core:CurrentFinancialInstruments 2023-05-01 2024-04-30 11967547 core:Non-currentFinancialInstruments 2023-05-01 2024-04-30 11967547 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 11967547 bus:OrdinaryShareClass1 2022-05-01 2023-04-30 11967547 bus:OrdinaryShareClass2 2023-05-01 2024-04-30 11967547 bus:OrdinaryShareClass2 2022-05-01 2023-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 11967547 (England and Wales)

ROLE 1 MEDICAL LTD

Unaudited Financial Statements
For the financial year ended 30 April 2024
Pages for filing with the registrar

ROLE 1 MEDICAL LTD

Unaudited Financial Statements

For the financial year ended 30 April 2024

Contents

ROLE 1 MEDICAL LTD

BALANCE SHEET

As at 30 April 2024
ROLE 1 MEDICAL LTD

BALANCE SHEET (continued)

As at 30 April 2024
Note 2024 2023
£ £
Fixed assets
Intangible assets 3 0 2,000
Tangible assets 4 465,704 244,832
465,704 246,832
Current assets
Stocks 55,000 25,000
Debtors 5 616,532 337,400
Cash at bank and in hand 7,113 41,055
678,645 403,455
Creditors: amounts falling due within one year 6 ( 840,808) ( 693,820)
Net current liabilities (162,163) (290,365)
Total assets less current liabilities 303,541 (43,533)
Creditors: amounts falling due after more than one year 7 ( 142,484) ( 59,279)
Provision for liabilities 8 ( 34,304) 0
Net assets/(liabilities) 126,753 ( 102,812)
Capital and reserves
Called-up share capital 9 110 110
Profit and loss account 126,643 ( 102,922 )
Total shareholders' funds/(deficit) 126,753 ( 102,812)

For the financial year ending 30 April 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Role 1 Medical Ltd (registered number: 11967547) were approved and authorised for issue by the Director on 04 October 2024. They were signed on its behalf by:

Mr M A R Luscombe
Director
ROLE 1 MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2024
ROLE 1 MEDICAL LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Role 1 Medical Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Francis Clark Llp Unit 18, 23 Melville Building East, Royal William Yard, Plymouth, PL1 3GW, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Revenue from services is recognised as when the performance obligations specified in the transaction have been satisfied.

Employee benefits

Defined contribution schemes
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 5 years straight line
Goodwill

Goodwill arises on business combination and represents any excess of consideration given over the fair value of the identifiable assets and liabilities acquired. Goodwill is initially recognised as an intangible asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight line basis over its useful economic life, which is 5 years.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 25 % reducing balance
Vehicles 25 % reducing balance
Office equipment 3 years straight line
Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Profit and Loss Account over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 112 85

3. Intangible assets

Goodwill Total
£ £
Cost
At 01 May 2023 10,000 10,000
At 30 April 2024 10,000 10,000
Accumulated amortisation
At 01 May 2023 8,000 8,000
Charge for the financial year 2,000 2,000
At 30 April 2024 10,000 10,000
Net book value
At 30 April 2024 0 0
At 30 April 2023 2,000 2,000

4. Tangible assets

Plant and machinery Vehicles Office equipment Computer equipment Total
£ £ £ £ £
Cost
At 01 May 2023 68,561 331,739 0 9,187 409,487
Additions 63,624 311,606 2,848 530 378,608
At 30 April 2024 132,185 643,345 2,848 9,717 788,095
Accumulated depreciation
At 01 May 2023 22,471 137,156 0 5,028 164,655
Charge for the financial year 27,430 126,553 940 2,813 157,736
At 30 April 2024 49,901 263,709 940 7,841 322,391
Net book value
At 30 April 2024 82,284 379,636 1,908 1,876 465,704
At 30 April 2023 46,090 194,583 0 4,159 244,832

5. Debtors

2024 2023
£ £
Trade debtors 572,913 259,553
Prepayments and accrued income 43,619 77,847
616,532 337,400

6. Creditors: amounts falling due within one year

2024 2023
£ £
Bank loans and overdrafts (secured £ 19,974) 23,774 4,825
Trade creditors 74,927 101,435
Amounts owed to director 16,242 21,088
Accruals 4,000 ( 1)
Other taxation and social security 354,402 315,699
Obligations under finance leases and hire purchase contracts (secured) 122,993 60,661
Other creditors 244,470 190,113
840,808 693,820

Creditors include net obligations under hire purchase contracts which are secured against the assets themselves and bank loans which are secured against the director personally.

7. Creditors: amounts falling due after more than one year

2024 2023
£ £
Bank loans 4,159 7,917
Obligations under finance leases and hire purchase contracts 138,325 51,362
142,484 59,279

There are no amounts included above in respect of which any security has been given by the small entity.

8. Provision for liabilities

2024 2023
£ £
Deferred tax 34,304 0

9. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each (2023: 110 shares of £ 1.00 each) 100 110
10 Ordinary A shares of £ 1.00 each (2023: nil shares) 10 0
110 110

10. Financial commitments

Commitments

2024 2023
£ £
Total future minimum lease payments under non-cancellable operating lease 92,581 0